A transversal approach based on multidisciplinary team meetings model

• Screening tools and AI
• Genomic expression testing
• IDC and pre-malignant lesion
• Updated standards in HR+ non metastatic disease
• HER2+ non metastatic management
• Triple negative non metastatic
• Breast cancer in elderly women